diethylcarbamazine has been researched along with Parasitic Skin Diseases in 17 studies
Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.
Excerpt | Relevance | Reference |
---|---|---|
"We compared ivermectin with diethylcarbamazine for the treatment of onchocerciasis in a double-blind, placebo-controlled trial." | 9.05 | Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. ( Aziz, MA; Cupp, EW; D'Anna, SA; Goldschmidt, LP; Greene, BM; Murphy, RP; Newland, HS; Schulz-Key, H; Taylor, HR; White, AT, 1985) |
"We compared ivermectin with diethylcarbamazine for the treatment of onchocerciasis in a double-blind, placebo-controlled trial." | 5.05 | Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. ( Aziz, MA; Cupp, EW; D'Anna, SA; Goldschmidt, LP; Greene, BM; Murphy, RP; Newland, HS; Schulz-Key, H; Taylor, HR; White, AT, 1985) |
"In persons with onchocerciasis, topical application of the anthelminthic diethylcarbamazine (DEC) induces clinical and histologic responses similar to acute papular onchodermatitis, including recruitment of eosinophils to the skin." | 3.70 | Eotaxin expression in Onchocerca volvulus-induced dermatitis after topical application of diethylcarbamazine. ( Boatin, BA; Gilles, AA; Higgins, AW; Pearlman, E; Toé, L; Unnasch, TR, 1999) |
"Retreatment with diethylcarbamazine again caused pruritus, but this was tolerated as were subsequent treatments." | 1.26 | Subcutaneous nodules as a manifestation of onchocerciasis. A rare condition in the United States. ( Beaver, PC; Bray, DM; Grannis, FW; Palomar, JM, 1976) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (58.82) | 18.7374 |
1990's | 3 (17.65) | 18.2507 |
2000's | 2 (11.76) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Senanayake, MP | 1 |
Infaq, ML | 1 |
Adikaram, SG | 1 |
Udagama, PV | 1 |
Gaur, MK | 1 |
Goel, A | 1 |
Gupta, S | 1 |
Sbeity, ZH | 1 |
Jaksche, A | 1 |
Martin, S | 1 |
Loeffler, KU | 1 |
Cahill, KM | 1 |
Vermeer, BJ | 1 |
van der Kaay, HJ | 1 |
Rozenman, D | 1 |
Kremer, M | 1 |
Zuckerman, F | 1 |
Krautheim, H | 1 |
Edungbola, LD | 1 |
Takeuchi, T | 1 |
Pearlman, E | 1 |
Toé, L | 1 |
Boatin, BA | 1 |
Gilles, AA | 1 |
Higgins, AW | 1 |
Unnasch, TR | 1 |
Goljan, J | 1 |
Nahorski, W | 1 |
Tomaszewski, R | 1 |
Felczak-Korzybska, I | 1 |
Górski, J | 1 |
Connor, DH | 1 |
Palomar, JM | 1 |
Bray, DM | 1 |
Grannis, FW | 1 |
Beaver, PC | 1 |
Bergner, T | 1 |
Löscher, T | 1 |
Barutzki, D | 1 |
Przybilla, B | 1 |
Albiez, EJ | 1 |
Newland, HS | 2 |
White, AT | 2 |
Kaiser, A | 1 |
Greene, BM | 2 |
Taylor, HR | 2 |
Büttner, DW | 1 |
Cupp, EW | 1 |
Murphy, RP | 1 |
Aziz, MA | 1 |
Schulz-Key, H | 1 |
D'Anna, SA | 1 |
Goldschmidt, LP | 1 |
Duke, BO | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Safety and Efficacy of Combination Therapy With Ivermectin, Diethylcarbamazine, and Albendazole (IDA) for Individuals With Onchocerciasis[NCT04188301] | Phase 2 | 154 participants (Actual) | Interventional | 2019-12-06 | Completed | ||
Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis[NCT06070116] | Phase 2 | 300 participants (Anticipated) | Interventional | 2024-01-15 | Not yet recruiting | ||
Microfilarial Clearance From the Eye and Ocular Changes Associated With Ivermectin Treatment in Individuals With Onchocerciasis[NCT03517462] | 231 participants (Actual) | Interventional | 2018-08-06 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
The effectiveness of three treatment regimens for killing adult female O. volvulus worms based on the percentage of all adult female worms in nodules that are alive 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment
Intervention | Female worms in nodule (Count of Units) |
---|---|
IVM + ALB | 127 |
IDA x 1 Dose | 142 |
IDA x 3 Doses | 159 |
The effect of three treatment regimens for killing adult female O. volvulus worms will be compared based on the percentage of all adult female worms in nodules that are alive with embryos in the uterus 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment.
Intervention | Female worms in nodules (Count of Units) |
---|---|
IVM + ALB | 127 |
IDA x 1 Dose | 142 |
IDA x 3 Doses | 159 |
The effect of three treatment regimens for sterilizing adult female O. volvulus worms will be compared based on the percentage of all adult female worms that are fertile in the nodules 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment.
Intervention | Female worms with intact uterus (Count of Units) |
---|---|
IVM + ALB | 41 |
IDA x 1 Dose | 40 |
IDA x 3 Doses | 34 |
Rates of ocular adverse events of any grade within 3 months will be compared by treatment group. (NCT04188301)
Timeframe: within 3 months of treatment with IDA
Intervention | Participants (Count of Participants) |
---|---|
IVM + ALB | 4 |
IDA x 1 Dose | 4 |
IDA x 3 Doses | 3 |
Rates of adverse events grade 3 or higher that occur within 7 days of treatment in the subset of participants who have intraocular microfilariae just prior to treatment with IDA will be compared by treatment group. (NCT04188301)
Timeframe: within 7 days following end of treatment
Intervention | Participants (Count of Participants) |
---|---|
IVM + ALB | 0 |
IDA x 1 Dose | 0 |
IDA x 3 Doses | 0 |
Rates of severe adverse events (grade 3 or higher) following 1-day or 3-day triple drug treatment will be compared against those of the comparator regimen of 1 day of IVM/ALB. (NCT04188301)
Timeframe: Within 7 days following end of treatment
Intervention | Participants (Count of Participants) |
---|---|
IVM + ALB | 0 |
IDA x 1 Dose | 0 |
IDA x 3 Doses | 0 |
The effectiveness of three treatment regimens for preventing reappearance of microfilariae in the skin as determined by skin snips at 12 and 18 months after treatment will be compared by treatment arm. Measured by the presence of microfilariae in skin snips. (NCT04188301)
Timeframe: Baseline, 12 months, and 18 months following treatment
Intervention | Count of microfilarae+ participants (Number) | ||
---|---|---|---|
Baseline | Month 12 | Month 18 | |
IDA x 1 Dose | 6 | 21 | 15 |
IDA x 3 Doses | 0 | 21 | 17 |
IVM + ALB | 7 | 23 | 20 |
The effectiveness of three treatment regimens for complete clearance of microfilariae from the skin as determined by skin snips at 3, 12, and 18 months after treatment with IDA will be compared by treatment arm. (NCT04188301)
Timeframe: Baseline, 3 months, 12 months, & 18 months following treatment.
Intervention | Count of Skin Microfilaria (Geometric Mean) | |||
---|---|---|---|---|
Baseline | Month 3 | Month 12 | Month 18 | |
IDA x 1 Dose | 1.7 | 3 | 2.5 | 9.0 |
IDA x 3 Doses | NA | 2.1 | 4.7 | 8.6 |
IVM + ALB | 3.1 | 1.9 | 4.9 | 7.0 |
1 review available for diethylcarbamazine and Parasitic Skin Diseases
Article | Year |
---|---|
[Onchocerciasis].
Topics: Animals; Antiparasitic Agents; Diagnosis, Differential; Diethylcarbamazine; Filaricides; Humans; Ive | 1999 |
2 trials available for diethylcarbamazine and Parasitic Skin Diseases
Article | Year |
---|---|
Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
Topics: Adult; Animals; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-B | 1988 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
14 other studies available for diethylcarbamazine and Parasitic Skin Diseases
Article | Year |
---|---|
Ocular and subcutaneous dirofilariasis in a Sri Lankan infant: an environmental hazard caused by dogs and mosquitoes.
Topics: Animals; Diethylcarbamazine; Dirofilaria repens; Dirofilariasis; Eye Diseases; Filaricides; Humans; | 2013 |
An elephantine problem.
Topics: Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Male; Skin Disease | 2017 |
Loa loa macrofilariasis in the eyelid: case report of the first periocular subcutaneous manifestation in Germany.
Topics: Adult; Africa; Animals; Diethylcarbamazine; Eye Infections, Parasitic; Eyelid Diseases; Female; Fila | 2006 |
Bancroftian filarial nodule. Report of a case.
Topics: Adult; Complement Fixation Tests; Diethylcarbamazine; Filariasis; Granuloma; Humans; Male; Skin Dise | 1967 |
Loiasis: a case report.
Topics: Adult; Diethylcarbamazine; Eyelid Diseases; Female; Filariasis; Humans; Loiasis; Netherlands; Nigeri | 1982 |
Onchocerciasis in Israel.
Topics: Adolescent; Diagnosis, Differential; Diethylcarbamazine; Ethiopia; Eye Diseases; Humans; Israel; Mal | 1984 |
[Loaiasis. Clinical aspects and therapy in the field of dermatology].
Topics: Adult; Antiparasitic Agents; Diagnosis, Differential; Diethylcarbamazine; Female; Filariasis; Humans | 1982 |
Prevalence of onchocerciasis in Ile-Ire District, (Ifelodun), Kwara State, Nigeria.
Topics: Adolescent; Adult; Aged; Blindness; Child; Child, Preschool; Diethylcarbamazine; Female; Humans; Inf | 1982 |
Eotaxin expression in Onchocerca volvulus-induced dermatitis after topical application of diethylcarbamazine.
Topics: Administration, Topical; Adolescent; Animals; Antiparasitic Agents; Chemokine CCL11; Chemokines, CC; | 1999 |
Diagnosing and treatment of skin filariases based on own observations.
Topics: Adolescent; Adult; Antiparasitic Agents; Diethylcarbamazine; Female; Filariasis; Filaricides; Humans | 2000 |
Onchocercal dermatitis-current concepts of pathogenesis.
Topics: Dermatitis; Diethylcarbamazine; Humans; Onchocerciasis; Skin; Skin Diseases, Parasitic | 1978 |
Subcutaneous nodules as a manifestation of onchocerciasis. A rare condition in the United States.
Topics: Adult; Antiparasitic Agents; Diethylcarbamazine; Female; Humans; Onchocerciasis; Skin; Skin Diseases | 1976 |
[Subcutaneous dirofilariasis: infection with Dirofilaria repens].
Topics: Animals; Antiparasitic Agents; Diethylcarbamazine; Dirofilaria; Dirofilariasis; Facial Dermatoses; F | 1990 |
Onchocerciasis.
Topics: Africa; Central America; Diagnosis, Differential; Diethylcarbamazine; Eye Manifestations; Humans; On | 1968 |